Cerebellar ataxia in pediatric patients with langerhans cell histiocytosis

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 11, 2004, Pages 735-739

  Imashuku, Shinsaku ^a   Ishida, Shuichi ^b   Koike, Kenichi ^b   Ichikawa, Motoki ^b   Minato, Toshinori ^c   Suzuki, Yoshihisa ^d   Kobayashi, Ryoji ^d   Morimoto, Akira ^e  

^a KYOTO CITY HOSPITAL   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Toyooka Hospital   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Ataxia; Central nervous system lesions; Cerebellar involvement; Langerhans cell histiocytosis; Magnetic resonance imaging

Indexed keywords

CYTARABINE; DEXAMETHASONE; IMMUNOGLOBULIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINBLASTINE; VINCRISTINE;

AGE DISTRIBUTION; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CHILD; DEVELOPMENTAL DISORDER; DIABETES INSIPIDUS; HISTIOCYTOSIS; HUMAN; LANGERHANS CELL HISTIOCYTOSIS; MALE; ONSET AGE; PEDIATRICS; PRIORITY JOURNAL;

AGE OF ONSET; CEREBELLAR ATAXIA; CHILD; CHILD, PRESCHOOL; DIABETES INSIPIDUS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES;

EID: 9644279605     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200411000-00009     Document Type: Article

References (23)

1. Hund E, Steiner H, Jansen O, et al. Treatment of cerebral Langerhans cell histiocytosis. J Neurol Sci. 1999;171:145-152.
2. Grois NG, Favara BE, Mostbeck GH, et al. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:287-305.
3. Grois N, Barkovich AJ, Rosenau W, et al. Central nervous system associated with Langerhans' cell histiocytosis. Am J Pediatr Hematol Oncol. 1993;15:245-254.
4. Haslam RH, Clark DB. Progressive cerebellar ataxia associated with Hand-Schuller-Christian disease. Dev Med Child Neurol. 1971;13:174-179.
5. Adornato BT, Eil C, Head GL, et al. Cerebellar involvement in multifocal eosinophilic granuloma: demonstration by computerized tomographic scanning. Ann Neurol. 1980;7:125-129.
6. Polizzi A, Coghill S, McShane MA, et al. Acute ataxia complicating Langerhans cell histiocytosis. Arch Dis Child. 2002;86:130-131.
7. Barthez MA, Araujo E, Donadieu J. Langerhans cell histiocytosis and the central nervous system in childhood: evolution and prognostic factors. Results of a collaborative study. J Child Neurol. 2000;15:150-156.
8. Poe LB, Dubowy RL, Hochhauser L, et al. Demyelinating and gliotic cerebellar lesions in Langerhans cell histiocytosis. AJNR Am J Neuroradiol. 1994;15:1921-1981.
9. Fukazawa T, Yanagihara T, Hamada K, et al. Multifocal eosinophilic granuloma presenting as progressive brainstem and cerebellar dysfunction. J Neurol Neurosurg Psychiatry. 1994;57:980-982.
10. Goldberg-Stern H, Weitz R, Zaizov R, et al. Progressive spinocerebellar degeneration "plus" associated with Langerhans cell histiocytosis: a new paraneoplastic syndrome? J Neurol Neurosurg Psychiatry. 1995;58:180-183.
11. Shuper A, Stark B, Yaniv Y, et al. Cerebellar involvement in Langerhans' cell histiocytosis: a progressive neuropsychiatric disease. J Child Neurol. 2000;15:824-826.
12. Ikushima S, Kinugawa N, Hibi S, et al. Multiinstitutional trials in the treatment of pediatric patients with Langerhans cell histiocytosis: therapeutic results treated by protocol JLSG-96. Jpn J Pediatr Hematol. 2002;16:135-142.
13. Whitsett SF, Kneppers K, Coppes MJ, et al. Neuropsychiatric deficits in children with Langerhans cell histiocytosis. Med Pediatr Oncol. 1999;33: 486-492.
14. Calming U, Bemstrand C, Mosskin M, et al. Brain 18-FDG PET scan in central nervous system Langerhans cell histiocytosis. J Pediatr. 2002; 141:435-440.
15. Watts J, Files B. Langerhans cell histiocytosis: central nervous system involvement treated successfully with 2-chlorodeoxyadenosine. Pediatr Hematol Oncol. 2001;18:199-204.
16. Gupta M, Noel GJ, Schaefer M, et al. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol. 2001;21:193-199.
17. Finsterer J, Grass R, Stollberger C, et al. Immunoglobulins in acute, para-infectious, disseminated encephalo-myelitis. Clin Neuropharmacol. 1998; 21:258-261.
18. Sahlas DJ, Miller SP, Guerin M, et al. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 2000; 54:1370-1372.
19. Daaboul Y, Vern BA, Blend MJ. Brain SPECT imaging and treatment with IVIG in acute post-infectious cerebellar ataxia: case report. Neurol Res. 1998;20:85-88.
20. Harukawa H, Yuasa T. Progress of the therapy for virus-related neurological disorders. Nippon Rinsho. 1997;55:959-966.
21. McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Ren Infect Dis. 1987;9:334-356.
22. Kleyweg RP, van der Meche FG, Meulstee J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology. 1988;38:1639-1641.
23. Gurer YK, Kukner S, Sarica B. Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis. Pediatr Neurol. 1996;14:72-74.